Catalent (Germany) Performance
| 0C8 Stock | EUR 58.55 0.32 0.55% |
Catalent has a performance score of 12 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.13, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Catalent's returns are expected to increase less than the market. However, during the bear market, the loss of holding Catalent is expected to be smaller as well. Catalent right now shows a risk of 0.85%. Please confirm Catalent information ratio, total risk alpha, treynor ratio, as well as the relationship between the jensen alpha and sortino ratio , to decide if Catalent will be following its price patterns.
Risk-Adjusted Performance
12 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Catalent are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady basic indicators, Catalent may actually be approaching a critical reversion point that can send shares even higher in January 2025. ...more
| Begin Period Cash Flow | 896 M | |
| Total Cashflows From Investing Activities | -1.9 B |
Catalent |
Catalent Relative Risk vs. Return Landscape
If you would invest 5,384 in Catalent on September 12, 2024 and sell it today you would earn a total of 471.00 from holding Catalent or generate 8.75% return on investment over 90 days. Catalent is currently producing 0.1347% returns and takes up 0.8535% volatility of returns over 90 trading days. Put another way, 7% of traded stocks are less volatile than Catalent, and 98% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Catalent Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Catalent's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Catalent, and traders can use it to determine the average amount a Catalent's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1578
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | 0C8 | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 0.85 actual daily | 7 93% of assets are more volatile |
Expected Return
| 0.13 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average Catalent is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Catalent by adding it to a well-diversified portfolio.
Catalent Fundamentals Growth
Catalent Stock prices reflect investors' perceptions of the future prospects and financial health of Catalent, and Catalent fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Catalent Stock performance.
| Return On Equity | 0.0873 | |||
| Return On Asset | 0.041 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.15 % | |||
| Current Valuation | 11.57 B | |||
| Shares Outstanding | 180.09 M | |||
| Price To Earning | 44.99 X | |||
| Price To Book | 1.76 X | |||
| Price To Sales | 1.57 X | |||
| Revenue | 4.83 B | |||
| EBITDA | 1.11 B | |||
| Cash And Equivalents | 227.9 M | |||
| Cash Per Share | 1.56 X | |||
| Total Debt | 4.17 B | |||
| Debt To Equity | 134.90 % | |||
| Book Value Per Share | 27.29 X | |||
| Cash Flow From Operations | 439 M | |||
| Earnings Per Share | 2.14 X | |||
| Total Asset | 10.51 B | |||
About Catalent Performance
By analyzing Catalent's fundamental ratios, stakeholders can gain valuable insights into Catalent's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Catalent has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Catalent has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Catalent, Inc. provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products worldwide. Catalent, Inc. was founded in 2007 and is headquartered in Somerset, New Jersey. Catalent operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 11000 people.Things to note about Catalent performance evaluation
Checking the ongoing alerts about Catalent for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Catalent help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Catalent has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Over 100.0% of the company shares are owned by institutions such as pension funds |
- Analyzing Catalent's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Catalent's stock is overvalued or undervalued compared to its peers.
- Examining Catalent's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Catalent's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Catalent's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Catalent's stock. These opinions can provide insight into Catalent's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Catalent Stock analysis
When running Catalent's price analysis, check to measure Catalent's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Catalent is operating at the current time. Most of Catalent's value examination focuses on studying past and present price action to predict the probability of Catalent's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Catalent's price. Additionally, you may evaluate how the addition of Catalent to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |